Načítá se...
Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
Increased asthma severity is not only associated with enhanced recurrent hospitalization and mortality but also with higher social costs. Several cases of asthma are atopic in nature, with the trigger for acute asthma attacks and chronic worsening of inflammation being allergens inducing an immune,...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4113133/ https://ncbi.nlm.nih.gov/pubmed/24735949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2049-6958-9-23 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|